Imagent: profile and news






IMCOR Pharmaceutical Co., Alliance Pharmaceutical Corp., Molecular ...  Sep 22, 2005
...with the license agreement, IMCOR and Alliance reached an agreement freeing each party of its continuing obligations under the original Imagent(R) (perflexane ... - PR Newswire (press release),

IMCOR Pharmaceutical Co. Receives Notice of Allowance of IMCOR's ...  Apr 11, 2005
Its FDA approved product, Imagent(R), is indicated for use in patients with suboptimal echocardiograms to opacify the left ventricle and thereby improve ... - PharmaLive.com,

IMCOR Pharmaceutical Co. Announces Reverse Split  Mar 4, 2005
Its FDA approved product, Imagent, is indicated for use in patients with suboptimal echocardiograms to opacify the left ventricle and thereby improve ... - Business Wire (press release),

IMCOR Pharmaceutical Co. Appoints Jack DeFranco to Chief Operating ...  Feb 22, 2005
Dr. Williams further stated, "Jack joined the company as part of the acquisition of the Imagent Business in June of 2003 and he has made significant ... - PharmaLive.com (press release),


Home | About | Cancers | Treatment | Medications
Copyright onconews.org 2005.
All Rights Reserved.
Google
 
Web onconews.org